Skip to main content
ABSTRACT & COMMENTARY

Metformin Reduces SARS-CoV-2 Viral Load in Outpatients with COVID-19

A randomized, placebo-controlled clinical trial of outpatients with COVID-19 found that metformin reduced SARS-CoV-2 viral load 3.6-fold compared to placebo, while ivermectin and fluvoxamine showed no benefit.